State Street Corp's Strategic Acquisition in Beam Therapeutics Inc

By Yahoo! Finance | Oct 17, 2024 at 03:13 PM EST

State Street Corp acquired 3,929,557 shares of Beam Therapeutics at $24.5 per share, strengthening its investment portfolio in the biotechnology sector. This strategic move aligns with the firm's focus on innovative companies and long-term growth.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.